Waldencast plc Files Form 25 to Voluntary Delist from Nasdaq and Deregister its Securities under the Exchange Act

Waldencast filed SEC Form 25 to delist its Class A ordinary shares and $11.50-exercise-price redeemable warrants from Nasdaq and deregister them under Exchange Act Section 12(b). The company expects the securities' final Nasdaq trading day to be approximately October 2, 2026, reducing public-market liquidity and access for shareholders.

Analysis

This is primarily a liquidity and governance repricing, not yet evidence of an operating inflection or a value-realization event. Once WALD loses its exchange venue, institutional ownership eligibility, index/passive demand, analyst coverage, and borrow availability can deteriorate quickly; the resulting OTC discount can exceed any change in intrinsic value. The warrants are particularly vulnerable: impaired price discovery and limited ability to monetize residual option value can make them trade at a disproportionate discount to modeled value.

Over the next several trading days, any remaining exchange liquidity is likely to be concentrated in forced exits rather than fundamental buyers. A 1-3 month recovery case requires a separately disclosed catalyst—such as a funded tender offer, strategic sale process, audited financial disclosure, or a credible relisting path. The filing itself does not establish any of these, and investors should not assume that deregistration automatically means reporting obligations or creditor protections disappear immediately.

The contrarian case is that an OTC transition creates an artificial discount and a controlling shareholder could ultimately monetize assets at a premium. That is an event-driven option, however, not a base-case long thesis: absent disclosed ownership, net debt, covenant headroom, cash generation, and a transaction structure, the discount is not reliably arbitrageable. Falsification of the bearish liquidity thesis would be a binding tender/merger agreement at a premium, sustained OTC market-making depth, or management committing to full periodic reporting after the transition.

Key Decisions for Investors

• Exit or avoid new long WALD common exposure before the final Nasdaq session unless there is a disclosed transaction price that provides a defined spread; treat post-transition positions as private-market-like liquidity risk rather than listed equity exposure.
• Do not initiate a directional short in WALD solely on the delisting catalyst: borrow can be recalled, locate costs can spike, and an undisclosed strategic transaction creates asymmetric gap risk. Reassess only if borrow remains stable and exchange-traded liquidity supports a tightly controlled position.
• Sell or avoid WALD warrants rather than averaging down; their $11.50 strike value is unlikely to be realizable efficiently without transparent OTC liquidity and a clearly observable common-share market. Retain only as a small event-option position if a formal tender or merger process emerges.
• Set an alert for an SEC filing detailing post-transition reporting status, ownership/control changes, debt amendments, or a tender/merger proposal. A cash offer with a fixed consideration would convert the situation into a merger-arbitrage review; until then, there is no clean risk-adjusted trade.